Raymond Wadlow, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Consulting Fee
    Ineligible company: 
    Bristol Myers Squibb
    Topic: 
    Colorectal Cancer
    Date added: 
    04/24/2023
    Mitigation strategy: 
    Attest
    Relationship end date: 
    12/31/2023
    Date reviewed: 
    11/03/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consulting Fee
    Ineligible company: 
    Exact Sciences
    Topic: 
    Colorectal Cancer
    Date added: 
    04/24/2023
    Mitigation strategy: 
    Attest
    Relationship end date: 
    01/25/2023
    Date reviewed: 
    11/03/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consulting Fee
    Ineligible company: 
    Taiho
    Topic: 
    Colorectal Cancer
    Date added: 
    04/24/2023
    Mitigation strategy: 
    Attest
    Relationship end date: 
    03/30/2023
    Date reviewed: 
    11/03/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consulting Fee
    Ineligible company: 
    Seagen
    Topic: 
    Colorectal Cancer
    Date added: 
    04/24/2023
    Mitigation strategy: 
    Attest
    Relationship end date: 
    10/25/2022
    Date reviewed: 
    11/03/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consulting Fee
    Ineligible company: 
    Pfizer
    Topic: 
    Colorectal Cancer
    Date added: 
    04/24/2023
    Mitigation strategy: 
    Attest
    Relationship end date: 
    12/31/2023
    Date reviewed: 
    11/03/2023
Return to 2023 Inova Fairfax/IFOH GI Tumor Board Conference 11/15/2023